Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence Imaging for Bowel Anastomosis in Gynecologic Oncology
NCT06871787Phase 4Not yet recruiting
- Sponsor
- Istanbul University
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of indocyanine green in gynecologic cancer, sponsored by Istanbul University. Primary endpoint: Rate of Anastomotic Complications within 30 Days After Surgery. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
gynecologic cancer
Beyond the preview
Go deeper on NCT06871787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06871787.